These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 22824596

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pre-operative use of the topical steroidal and non-steroidal anti-inflammatory agents to maintain intra-operative mydriasis during cataract surgery.
    Joshi RS.
    Indian J Ophthalmol; 2013 May; 61(5):246-7. PubMed ID: 23760455
    [No Abstract] [Full Text] [Related]

  • 3. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
    Duong HV, Westfield KC, Chalkley TH.
    J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
    [Abstract] [Full Text] [Related]

  • 4. Effect of Topical Nonsteroidal Anti-inflammatory Drugs on Pupillary Size During Uncomplicated Cataract Surgery.
    Rodríguez-García A, Hernández-Camarena JC, López-Jaime GR, Nava-García JA.
    J Refract Surg; 2017 Apr 01; 33(4):236-242. PubMed ID: 28407163
    [Abstract] [Full Text] [Related]

  • 5. Preoperative anti-inflammatory treatment of diabetic patients does not improve recovery from cataract surgery when postoperatively treated with a combination of prednisolone acetate and nepafenac.
    Danni R, Viljanen A, Aaronson A, Tuuminen R.
    Acta Ophthalmol; 2019 Sep 01; 97(6):589-595. PubMed ID: 30620140
    [Abstract] [Full Text] [Related]

  • 6. Comparison of preoperative nepafenac (0.1%) and flurbiprofen (0.03%) eye drops in maintaining mydriasis during small incision cataract surgery in patients with senile cataract: A randomized, double-blind study.
    Sarkar S, Mondal KK, Roy SS, Gayen S, Ghosh A, De RR.
    Indian J Pharmacol; 2015 Sep 01; 47(5):491-5. PubMed ID: 26600636
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
    Simone JN, Pendelton RA, Jenkins JE.
    J Cataract Refract Surg; 1999 May 01; 25(5):699-704. PubMed ID: 10330648
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety and Efficacy of 0.1% Nepafenac versus 1% Prednisolone Acetate Eye Drops after Laser Peripheral Iridotomy: A Prospective, Randomized Trial.
    Gayam K, Ramulu PY, Rengaraj V, Srinivasan K.
    Ophthalmol Glaucoma; 2020 May 01; 3(3):174-180. PubMed ID: 32672612
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial.
    Ticly FG, Lira RP, Zanetti FR, Machado MC, Rodrigues GB, Arieta CE.
    J Ocul Pharmacol Ther; 2014 Aug 01; 30(6):495-501. PubMed ID: 24735005
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy.
    Nagpal M, Lambat S, Mehrotra N, Paranjpe G, Yadav H, Bhardwaj S.
    Indian J Ophthalmol; 2014 May 01; 62(5):606-9. PubMed ID: 24881610
    [Abstract] [Full Text] [Related]

  • 13. Topical levofloxacin, nepafenac and prednisolone acetate medication after cataract surgery in the biggest tertiary eye hospital in Finland during 2015-2018.
    Loukovaara S, Lehtinen V, Nieminen R, Moilanen J.
    Acta Ophthalmol; 2019 Sep 01; 97(6):e943-e945. PubMed ID: 30916844
    [No Abstract] [Full Text] [Related]

  • 14. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
    Sahu S, Ram J, Bansal R, Pandav SS, Gupta A.
    J Cataract Refract Surg; 2015 Oct 01; 41(10):2043-8. PubMed ID: 26703278
    [Abstract] [Full Text] [Related]

  • 15. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).
    Durrie DS, Kennard MG, Boghossian AJ.
    Adv Ther; 2007 Oct 01; 24(6):1278-85. PubMed ID: 18165210
    [Abstract] [Full Text] [Related]

  • 16. 0.1% Nepafenac reduces pain and increases patient comfort during cataract surgery.
    Oğurel T, Oğurel R, Onaran Z, Örnek K.
    Cont Lens Anterior Eye; 2018 Oct 01; 41(5):448-451. PubMed ID: 29807771
    [Abstract] [Full Text] [Related]

  • 17. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
    Hirneiss C, Neubauer AS, Kampik A, Schönfeld CL.
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug 01; 243(8):768-73. PubMed ID: 15756571
    [Abstract] [Full Text] [Related]

  • 18. Topical nepafenac inhibits ocular neovascularization.
    Takahashi K, Saishin Y, Saishin Y, Mori K, Ando A, Yamamoto S, Oshima Y, Nambu H, Melia MB, Bingaman DP, Campochiaro PA.
    Invest Ophthalmol Vis Sci; 2003 Jan 01; 44(1):409-15. PubMed ID: 12506103
    [Abstract] [Full Text] [Related]

  • 19. Tolerability and toxicity of topically applied nepafenac 0.3% compared with generic ketorolac 0.5.
    Hovanesian J, Holland E.
    J Cataract Refract Surg; 2019 Feb 01; 45(2):174-180. PubMed ID: 30527440
    [Abstract] [Full Text] [Related]

  • 20. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.
    Heier JS, Topping TM, Baumann W, Dirks MS, Chern S.
    Ophthalmology; 2000 Nov 01; 107(11):2034-8;discussion 2039. PubMed ID: 11054327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.